Exencial Wealth Advisors LLC lifted its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 1.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,134 shares of the pharmacy operator’s stock after acquiring an additional 207 shares during the period. Exencial Wealth Advisors LLC’s holdings in Walgreens Boots Alliance were worth $1,274,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also recently made changes to their positions in WBA. Horan Capital Advisors LLC. purchased a new stake in Walgreens Boots Alliance in the first quarter worth approximately $25,000. Massey Quick Simon & CO. LLC purchased a new stake in Walgreens Boots Alliance in the fourth quarter worth approximately $27,000. Murphy Pohlad Asset Management LLC purchased a new stake in Walgreens Boots Alliance in the fourth quarter worth approximately $29,000. Trustcore Financial Services LLC purchased a new stake in Walgreens Boots Alliance in the first quarter worth approximately $31,000. Finally, PRW Wealth Management LLC purchased a new stake in Walgreens Boots Alliance in the fourth quarter worth approximately $34,000. 63.84% of the stock is owned by institutional investors.
Shares of Walgreens Boots Alliance stock opened at $51.61 on Friday. The firm has a market cap of $48.24 billion, a PE ratio of 8.57, a price-to-earnings-growth ratio of 1.07 and a beta of 0.77. Walgreens Boots Alliance Inc has a 1-year low of $51.36 and a 1-year high of $86.31. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.38 and a current ratio of 0.78.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 12th. Stockholders of record on Monday, May 20th will be paid a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 3.41%. The ex-dividend date is Friday, May 17th. Walgreens Boots Alliance’s dividend payout ratio is presently 29.24%.
In related news, CAO Marco Patrick Anthony Pagni sold 20,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $53.05, for a total transaction of $1,061,000.00. Following the transaction, the chief accounting officer now owns 435,811 shares in the company, valued at approximately $23,119,773.55. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, COO Ornella Barra bought 18,000 shares of the stock in a transaction that occurred on Wednesday, April 3rd. The shares were purchased at an average price of $54.56 per share, for a total transaction of $982,080.00. Following the purchase, the chief operating officer now owns 26,425 shares in the company, valued at approximately $1,441,748. The disclosure for this purchase can be found here. Company insiders own 15.73% of the company’s stock.
Several equities research analysts recently issued reports on the stock. Pivotal Research dropped their target price on shares of Walgreens Boots Alliance from $70.00 to $60.00 and set a “hold” rating on the stock in a report on Wednesday, April 3rd. UBS Group dropped their target price on shares of Walgreens Boots Alliance from $60.00 to $49.00 and set a “sell” rating on the stock in a report on Wednesday, April 3rd. Cowen restated a “hold” rating and issued a $66.00 target price on shares of Walgreens Boots Alliance in a report on Sunday, March 31st. ValuEngine cut shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Wednesday, April 3rd. Finally, Guggenheim assumed coverage on shares of Walgreens Boots Alliance in a report on Thursday, April 18th. They issued a “neutral” rating and a $59.00 target price on the stock. Five analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $67.89.
COPYRIGHT VIOLATION NOTICE: This piece was first posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.baseballdailydigest.com/news/2019/05/24/exencial-wealth-advisors-llc-has-1-27-million-position-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Story: What are gap-down stocks?
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.